• Explore /
  • Poster
  • / ZUMA-8: A phase 1/2 multicenter study evaluating KTE-X19 in patients (pts) with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL).

ZUMA-8: A phase 1/2 multicenter study evaluating KTE-X19 in patients (pts) with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL).

Abstract Poster

Authors

Ian Flinn

Ian Flinn

Sarah Cannon Research Institute, Nashville, TN

Ian Flinn , Michael Marris , William G. Wierda , Steven Coutre , John M. Pagel , John C. Byrd , Lovely Goyal , Krista Goodman , Yan Zheng , Francesca Milletti , Swaminathan Murugappan , Jennifer R. Brown

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Sub Track

Chronic Lymphocytic Leukemia (CLL) and Hairy Cell

Clinical Trial Registration Number

NCT03624036

Citation

J Clin Oncol 37, 2019 (suppl; abstr TPS7566)

DOI

10.1200/JCO.2019.37.15_suppl.TPS7566

Abstract #

TPS7566

Poster Bd #

320a

Abstract Disclosures

Similar Posters

First Author: Loretta J. Nastoupil

First Author: Zhi Yang

First Author: Frederick L. Locke

First Author: Hui Liu